Our news
AACR 2026 and AACR Cancer Discovery Article
Â鶹´«Ã½ Press Release: AACR 2026 and AACR Cancer Discovery Article London UK, 21 April 2026 Â鶹´«Ã½, an immuno-oncology company, announces the …
Â鶹´«Ã½'s CEO Presents at Morgan Stanley 23rd Annual Global Healthcare Conference | September 2025
Â鶹´«Ã½'s CEO - Michael Shih - recently presented the Â鶹´«Ã½ story at the Morgan Stanley Global Healthcare Conference on Monday September 8th …
Â鶹´«Ã½ appoints Michael Shih as Chief Executive Officer
Â鶹´«Ã½ appoints Michael Shih as Chief Executive Officer Highly experienced corporate development leader with a track record of international pharma …
Â鶹´«Ã½ closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
Â鶹´«Ã½ closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore …
Other news
CEO Jeff Roix spoke to BioCentury about how Â鶹´«Ã½ Ltd is developing small molecules to inhibit DNA mismatch repair (MMR) and create a pool of …
APM Health: Interview with CEO, Jeff Roix
Scrip Emerging company profile: UK-based Â鶹´«Ã½, founded in 2017, is developing novel cancer therapies based on DNA-repair technology. The company …